MarketWatch
The Wall Street Journal
Digital Network
Business Wire
press release
April 29, 2011, 5:07 p.m. EDT
TROY, Mont., Apr 29, 2011 (BUSINESS WIRE) — In an April 22, 2011 letter to FDA Commissioner; Dr. Margaret Hamburg, Norma Erickson on behalf of the SaneVax Inc. Board of Directors, criticized the FDA for not following its own guidelines and recommendations in approving Roche’s cobas HPV Test for cervical cancer screening and for HPV-16 and HPV-18 genotyping.





